Search for: "Bayer v. Bayer" Results 281 - 300 of 1,119
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Mar 2015, 12:23 pm
  Never too late 33 [week ending Sunday 15 February] –-Evoking Audrey Hepburn’s image is not OK in Italy | Reasonable royalty and moral prejudice: new reference to the CJEU | CoA for England and Wales on parallel importations in Speciality European Pharma Ltd v Doncaster Pharmaceuticals Group Ltd & Madaus GmbH | The Logic of Innovation: Intellectual Property, and What the User Found There and Tritton on Intellectual Property in Europe reviewed | Italian baked… [read post]
6 Mar 2015, 5:00 am
Bayer Healthcare Pharmaceuticals, No. 5:14-cv-00101, 2015 U.S. [read post]
2 Mar 2015, 2:43 pm
Never too late 33 [week ending Sunday 15 February] –- Evoking Audrey Hepburn’s image is not OK in Italy | Reasonable royalty and moral prejudice: new reference to the CJEU | CoA for England and Wales on parallel importations in Speciality European Pharma Ltd v Doncaster Pharmaceuticals Group Ltd & Madaus GmbH | The Logic of Innovation: Intellectual Property, and What the User Found There and Tritton on Intellectual Property in Europe reviewed | Italian baked goods’… [read post]
27 Feb 2015, 4:58 am
  Ironically, one of the cases cited for “these standards” was Carrera v. [read post]
23 Feb 2015, 2:55 am
*****  PREVIOUSLY, ON NEVER TOO LATE Never too late 33 [week ending Sunday 15 February] –- Evoking Audrey Hepburn’s image is not OK in Italy | Reasonable royalty and moral prejudice: new reference to the CJEU | CoA for England and Wales on parallel importations in Speciality European Pharma Ltd v Doncaster Pharmaceuticals Group Ltd & Madaus GmbH  | The Logic of Innovation: Intellectual Property, and What the User Found There and Tritton on… [read post]
16 Feb 2015, 1:44 am
  * Bayer feels the pain: branded Naproxen can't invoke the territoriality principleKatfriend Marty Schwimmer reports on Belmora LLC v Bayer Consumer Care AG and Bayer Healthcare LLC, 1:14-cv-00847-GBL (EDVA Feb. 6, 2015), a recent US District Court for the Eastern District of Virginia ruling that deals with Article 6bis of the Paris Convention in the US as it applies to Bayer’s trade mark ‘FLANAX’. [read post]
11 Feb 2015, 12:23 pm
  Anyway, it is with great pleasure that the IPKat and Merpel welcome Marty has a guest contributor with the following item [Merpel calls it a "Marticle"] on a recent US District Court for the Eastern District of Virginia ruling, Belmora LLC v Bayer Consumer Care AG and Bayer Healthcare LLC, 1:14-cv-00847-GBL (EDVA Feb. 6, 2015), accessible here. [read post]
23 Jan 2015, 9:30 am
Bayer Corp., 727 F.3d 300 (3d Cir. 2013), and Marcus v. [read post]
20 Jan 2015, 11:46 am
Bayer Healthcare Pharma., Inc., 16 F.Supp.3d 1341 (N.D. [read post]
Rhodes and Karl Bayer Part Five: Incentives Through Expertise[1] In Part Four we began to discuss solutions (not just problems), and urged that a first step in incentivizing counsel to hold down litigation costs is to have a neutral oversee the process of discovery closely enough (1) to make it in counsel’s interest to act reason­ably in the first place; and (2) to rule on unreasonable demands or failures to respond to discovery quickly, so that they gain no tactical advantage. [read post]